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Abstract 
13C-NMR spectroscopy was employed non-invasively for the real-time measurement of the rates of glutathione synthesis in intact 
rabbit lenses supported in organ culture containing L-[3-13C]cysteine. Supplementation of the organ culture medium with 2-mercapto- 
ethanol resulted in a dose- dependent enhancement of lenticular glutathione synthesis rates (dose for 50% maximal effect = 125/zM). At 
the most effective concentration (400 /xM) 2-mercaptoethanol i creased the rate of glutathione synthesis 163% relative to the rate 
observed under control conditions. The mechanism of action for this effect was investigated in intact lenses using antagonists of specific 
amino acid uptake systems. These experiments demonstrated that the enhanced rates of glutathione synthesis observed in the presence of 
2-mercaptoethanol were due to 1:he affinity of the mixed-disulfide formed between cysteine and 2-mercaptoethanol for L system amino 
acid uptake, thereby providing amechanism for increasing intracellular cysteine levels by circumventing ormal cellular cysteine uptake 
pathways in the lens. Because of the role of cysteine as the rate limiting substrate in lenticular glutathione biosynthesis, these results 
suggest apotential strategy to prevent tissue opacification associated with depleted glutathione l vels. 
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1. Introduction 
Normally the mammalian crystallin lens is an optically 
transparent ocular tissue whose function is to transmit and 
focus visible light onto the retina. The loss of trans- 
parency, or clouding, of part or all of the tissue is the 
condition referred to as cataract. The etiology of this 
disorder is complex and only partially understood. Numer- 
ous risk factors, including diabetes, radiation, malnutrition 
and drug toxicity, are recognized as contributing to the 
disease [1-3]. The vast majority of cataracts are attributed 
to aging of the tissue, the so-called senile cataract. 
Glutathione (3~-glutamylcysteinylglycine) is the princi- 
pal component of the cellular thiol redox buffer of the lens. 
Levels up to 6 mM are found in the human lens, with 
concentrations a  high as 15 mM reported for rabbit lenses 
Abbreviations: GSH, glutathione; BSO, L-buthionine sulfoximine; 
2ME, 2-mercaptoethanol; FID, free induction decay; 13C-GSH, ([3- 
13C]cysteinyl)glutathione; (2ME-S-)2,2-hydroxyethyl disulfide; EDs0 ,
dose for 50% of maximal effect. 
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[4]. Glutathione possesses everal important biochemical 
functions, including detoxification of reactive metabolites, 
protection of protein thiol groups against irreversible oxi- 
dation, and regulation of various transport phenomena. In
the lens, glutathione is synthesized in situ from its constitu- 
tive amino acids, glycine, cysteine and glutamic acid, 
through the sequential reactions of 3,-glutamylcysteine syn- 
thetase and glutathione synthetase. 
Considerable vidence xists to suggest hat lenticular 
glutathione l vels are closely associated with tissue optical 
clarity. Blocking glutathione synthesis by the inhibition of 
3,-glutamylcysteine synthetase activity with L-buthionine 
sulfoximine depletes glutathione levels and causes tissue 
opacification in the lenses of mice [5]. Decreased glu- 
tathione levels are observed in the aging human lens [6], in 
certain types of human cataracts [7], and in many experi- 
mental models including, radiation [8,9], hyperglycemic 
and galactosemic [10] cataracts. 
Augmentation of glutathione l vels in the lens has been 
proposed as a possible strategy to prevent cataractogenesis 
associated with depletion of the tripeptide. Approaches 
employing lutathione ster analogs and various prodrugs 
have been suggested and a number of these have been 
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shown to increase glutathione tissue levels and delay or 
prevent opacity formation in experimental models [11-13]. 
An increase in glutathione levels resulting from en- 
hanced cellular cysteine uptake catalyzed by 2-mercapto- 
ethanol has been demonstrated in cell culture [14]. A 
similar effect by 2-mercaptoethanol has been observed in 
organ cultured rat lenses [15]. In the present study 13C- 
NMR spectroscopy [16] was used to non-invasively mea- 
sure the dose-response effect of 2-mercaptoethanol on 
[13]C-glutathione (13C-GSH) levels in the intact rabbit 
lens. The experimental pproach is further extended to 
examine pathways of lenticular cyst(e)ine uptake and the 
mechanism of action for the catalytic effect exerted by 
2-mercaptoethanol. 
widebore Oxford superconducting magnet, and interfaced 
to a General Electric 1280 computer system (GEM version 
12 software) was used. 13C-NMR spectra were acquired 
using a 12 mm broad band (15N-31p) probe tuned to 75.46 
MHz. Spectral acquisition parameters were: rf pulse, 45 ° 
tip angle; 4096 data points/FID; sweep width _+ 5000 Hz, 
quadrature detection; acquisition time, 204.8 ms; interpulse 
delay 1 s; 3000 accumulations per spectrum (60 min) or as 
noted in the text; bi-level proton decoupling. Bi-level 
proton decoupling powers were optimized for complete 
decoupling (high power) and maximum spectral nuclear 
Overhauser enhancement (low power). Sample heating 
from rf irradiation was monitored and not detected. 
2.4. NMR spectral analysis 
2. Materials and methods 
2.1. Materials 
L-[3-a3C]Cysteine (99 atom% 13C isotopic enrichmen0 
was obtained from Cambridge Isotopes. 2ME, L-leucine, 
L-glutamic acid, TC-199 medium and BSO were obtained 
from Sigma. All other eagents were obtained from Aldrich. 
2.2. Lens incubation 
All FIDs were multiplied by an exponential filter and 
zero-filled to 8192 data points prior to Fourier transforma- 
tion. 13C chemical shift values were expressed relative to 
13C-methanol (49.1 ppm) contained in a 5 /xl glass capil- 
lary tube placed in the NMR tube adjacent to the lenses. 
Resonance signal amplitudes and intensities were obtained 
using the GEM software package. Linear regression analy- 
sis of the data was performed using the Cricket Graph 
program (version 1.2) for the Macintosh computer. 
New Zealand White rabbits (0.9-1.2 kg) were used for 
all studies and were treated in accordance with University 
of California, Santa Cruz, Animal Care Committee guide- 
lines. Animals were sacrificed by CO 2 inhalation and the 
eyes enucleated. Globes were sterilized by immersion in 
1% betadine for 1 min and then rinsed with sterile phos- 
phate-buffered saline solution. Lenses were dissected and 
placed in TC-199/bicarbonate buffered incubation medium 
as previously described by Willis and Schleich [16]. All 
experimental media used contained 5.5 mM glucose with 
specific supplements (L-[3-13C]cysteine (13C-cysteine), 
2ME, L-leucine, L-glutamic acid, or BSO) added as de- 
scribed below. Final media osmolarities were adjusted to 
290 + 3 mosmol/1 with NaCI. 
Following dissection, paired lenses were placed directly 
in 10 mm (o.d.) NMR tubes equipped with inflow and 
outflow lines (PE-50 tubing, Intermedic) integrated into an 
organ culture perfusion assembly consisting of a medium 
reservoir connected to a low surge peristaltic pump (Model 
P-3, Pharmacia). This allowed for continuous tissue perfu- 
sion (ca. 1.5 ml h-1) during NMR data acquisition. Reser- 
voir medium was continually gassed with 5% CO 2 balance 
air mixture to maintain buffering capacity. The incubation 
temperature was maintained at 33°C using the variable 
temperature control on the NMR spectrometer. 
2.3. 13 C-NMR spectroscopy 
A General Electric GN-300 spectrometer operating in 
the Fourier transform mode, equipped with a 7.05 Tesla 
3. Results 
a3C-NMR spectroscopy in conjunction with 13C-cy- 
steine supplemented organ culture incubation was em- 
ployed to investigate the effect of 2-mercaptoethanol on 
glutathione synthesis in the intact rabbit lens. The results 
of studies demonstrating the feasibility of this experimen- 
tal approach to non-invasively measure glutathione bio- 
chemistry in intact tissue are shown in Fig. 1A-C. Under 
the conditions employed (33°C and 5% CO 2 balanced air 
saturated solution), the thiol group of cysteine in the 
medium was readily oxidized to form the disulfide, cys- 
tine, as shown by the presence of [3,3'-13C]cystine at39.3 
ppm (resonance 1) and the absence of 13C-cysteine (ex- 
pected chemical shift, 25.5 ppm) in the aaC-NMR spec- 
trum of 13C-cysteine (1 mM) supplemented medium (Fig. 
1A). The 13 C-NMR spectrum of paired rabbit lenses incu- 
bated in this medium for 24 h showed, in addition to the 
13C signal arising from cystine in the medium, a new 
resonance clearly resolved at 26.1 ppm (resonance 2) (Fig. 
1B). On the basis of the isotopic labeling pattern antici- 
pated from the biochemistry of lenticular glutathione syn- 
thesis, and from the known 13C-NMR chemical shift for 
the glutathione cysteinyl-C~ carbon [17,18], this resonance 
(labeled 2) was assigned to intralenticular ([3- 
13C]cysteinyl)glutathione (13C-GSH). The 13C-NMR spec- 
trum of a lens perfusate aliquot confirmed the intralenticu- 
lar origin of the 26.1 ppm 13C-GSH signal (cf., Figs. 1B 
and 5A). 
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Fig. 1. 13C-NMR spectra of (A) TC-199/bicarbonate-buffered medium 
containing 1mM [3-13C]cysteine; (B) a pair of intact rabbit lenses after 
24 h incubation i  1 mM [3-13C]cysteine m dium; (C) a pair of intact 
rabbit lenses after 24 h incubation in 1 mM [3-13C]eysteine medium 
supplemented with 2 mM BSO. Resonance assignments were as follows: 
(1) [3,3'JaC]cystine; (2) ([3-13C]cysteinyl)glutathione (13C-GSH). See 
Section 2 for lens organ culture methodology and NMR spectral cquisi- 
tion and processing parameters. 
Experimental verification of the 13C-GSH assignment 
was provided by the following experiment. Paired lenses 
were incubated in 13C-cysteine medium supplemented with 
2 mM BSO, a potent inhibitor of the first enzyme in the 
GSH biosynthetic pathway, y-glutamylcysteine synthetase 
[19]. The 26.1 ppm resonance assigned to laC-GSH was 
notably absent from the 13C-NMR spectrum of these lenses 
after 24 h of incubation (Fig. 1C), thereby providing 
13 confirmation of the assignment of this resonance to C- 
GSH, and demonstrating the efficacy of BSO for inhibiting 
glutathione synthesis in the intact rabbit lens. 
The relative rate of inta.ct lens glutathione synthesis 
under the perfused incubation condition of this study was 
determined from analysis of serial 13C-NMR spectra of 
paired rabbit lenses (Fig. 2). Lenticular 13C-GSH (reso- 
nance 2, 26.1 ppm) could be readily detected within 6 -7  h 
after the initiation of organ culture. Clearly apparent in this 
suite of spectra was a time-dependent increase in 13C-GSH 
levels. The 13C-GSH resonance amplitudes from these 
S~aceCtra were normalized to the signal intensity of the 
-methanol standard using the GEM software and plot- 
ted as a function of incubation time (see Fig. 4). Intralen- 
ticular 13C-GSH accumulation was observed to be linear 
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Fig. 2. Serial 13C-NMR spectra of paired rabbit lenses during incubation 
in 1 mM [3-13C]cysteine-supplemented tissue culture medium. Resonance 
assignments were as follows: (1) [3,3'-13C]cystine (39.3 ppm); (2) ([3- 
13C]cysteinyl)glutathione (26.1 ppm). See Section 2for lens organ culture 
methodology and NMR spectral cquisition and processing parameters. 
average relative rate of 13C-GSH synthesis from four 
separate control experiments (8 lenses) was 8.4 + 0.6 h-1. 
The effect of 2ME on lenticular 13C-GSH levels can be 
seen in the suite of 13C-NMR spectra shown in Fig. 3. 
Lenses were maintained in 13C-cysteine medium supple- 
mented with 400 ~M 2ME. 13C-GSH (resonance 2, 26.1 
ppm) was detected within 2 -4  h of initiating incubation 
and its levels increased in a linear fashion throughout he 
incubation as shown in Fig. 4. The relative rate of glu- 
tathione synthesis observed at 400/.~M 2ME (two experi- 
ments, four lenses) was 22.1 + 1.2 h -1. 
In contrast o controls (see Fig. 2), lenses incubated in 
2ME • 13 were characterized by the C-NMR spectral appear- 
ance and intralenticular accumulation of 13C-cysteine (res- 
onance 3, 25.5 ppm) as shown in Fig. 3. The 13C-NMR 
spectra (Fig. 5B) of a tissue culture medium aliquot from 
this lens incubation confirmed the intralenticular origins of 
the 13C-GSH and ~3C-cysteine signals observed in the 
intact lens spectra. Readily apparent in the spectrum of 
2ME supplemented medium, in addition to resonance 1 at 
39.3 ppm, was a new resonance (labeled 2) at 39.4 ppm, 
2 
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Fig. 3. Serial 13C-NMR spectra of paired rabbit lenses during incubation 
in 1 mM [3-13 C]cysteine tissue culture medium supplemented with 400 
~M 2-mercaptoethanol. Resonance assignments were as follows: (1) 
[3,3'J3C]cystine (39.3 ppm); (2) ([3J3C]cysteinyl)-glutathione (26.1 
ppm); (3) [3-13Clcysteine (25.5 ppm). See Section 2 for lens organ 
culture methodology and NMR spectral acquisition and processing pa- 
rameters. 
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Fig. 4. 13C-GSH resonance intensity as a function of incubation time 
from paired rabbit lens incubated in 1 mM [3-13C]cysteine tissue culture 
medium (©) and 1 mM [3-13C]cysteine m dium (0)  supplemented with 
400 /xM 2ME. Fitted lines were established bylinear egression. 
assigned to the mixed-disulfide formed through nucleo- 
philic disulfide exchange between cystine and the oxidized 
disulfide of 2ME, (2ME-S-)2: 
cystine + (2ME - S)2 ~" 2cysteine - 2ME (1) 
[cysteine - 2ME] 2 
K = [cystine] [(2ME - S)2] (2) 
The assignment of the 39.4 ppm resonance (2) to the 
mixed-disulfide was consistent with the ~3C chemical shift 
observed in these experiments, the chemistry of disulfide 
interchange reactions [20], and the results of chemical 
analysis [14]. Using the data given in Table 1, an equilib- 
rium constant (33°C) for the mixed-disulfide r action (Eq. 
(2)) of 3.8 _ 0.3 was measured. 
The dose response of glutathione synthesis to increasing 
concentrations of 2ME (0, 40, 200, 400, 600, and 1000 
/xM) was examined in intact lenses incubated in 13C-cy- 
steine (1 mM) medium. Lenses were continuously moni- 
tored by 13C-NMR spectroscopy, and analyzed as de- 
scribed above, to determine relative GSH synthesis rates. 
The results of these experiments are summarized in Table 
1. Increased rates of glutathione synthesis were observed at 
A 1 
B 
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Fig. 5.13C-NMR spectra of used lens incubation medium aliquots from 1 
mM [3-13C]cysteine supplemented tissue culture medium and [3-13C]cy - 
steine medium supplemented with 400/zM 2ME. Resonance assignments 
were as follows: (1) [3,y-13C]cystine (39.3 ppm); (2) [3-t3C]cysteine-2 - 
mercaptoethanol mixed disulfide (39.4 ppm). See Section 2 for NMR 
spectral acquisition and processing parameters. 
all 2ME concentrations tested, with the greatest effect 
observed at 400 /xM. The EDs0 for 2ME was estimated to 
be 125 /zM, which corresponded to ~ 120 /xM cysteine- 
2-mercaptoethanol mixed-disulfide. 
Supplementation f the organ culture medium (1 mM 
13C-cysteine, 0 mM 2ME) with 1 mM glutamic acid 
inhibited the relative rate of glutathione synthesis 45% 
relative to the average rate normally observed in lenses 
incubated without 2ME (4.6 h -1 vs. 8.4 h -1)  as shown in 
Fig. 6. The addition of 400/~M 2ME to the glutamic acid 
incubation medium at 13 h resulted in a 2-fold increase in 
glutathione synthesis rates to 9.6 h-1.  
The effect of 2ME on cysteine uptake was measured in 
intact lenses. Lenses were pre-incubated for 12-18 h in 
medium containing 2 mM BSO to inhibit y-glutamylcy- 
steine synthetase thereby blocking GSH synthesis and 
allowing direct observation of cysteine uptake. 13C-cy- 
steine (1 mM) was then added to the tissue culture medium 
and the levels of intracellular cysteine monitored as shown 
in Fig. 7. In the absence of 2ME, intralenticular 13C-cy- 
Table 1 
Dose-response effect of 2-mercaptoethanol o  lenticular glutathione synthesis 
2ME Concentration t3 C-Cys-2ME Number of Rate of GSH Percentage increase in
(/.~M) Concentration (mM) a lenses synthesis (h- 1) b rate of GSH synthesis c 
0 0 8 8.4 + 0.6 - 
40 39.6 d 2 12.9 53.6 
200 167 4 16.7 + 1.5 99.0 
400 287 4 22.1 + 1.2 163.3 
600 363 2 22.0 161.9 
1000 490 4 17.0 _+ 0.1 102.7 
a Concentrations were determined from X3C-NMR spectra of culture medium aliquots containing 1 mM 13C-cysteine 
designated. Spectra were acquired at 33°C using a 10 s interpulse delay, 16 382 data points per FID. 
b Reported relative rates represent the measured mean and standard deviation. 
c Percentage increase relative to the rate observed in control (0 /~M 2ME) lenses. 
Determined using Eq. (2) and assuming K = 3.8. 
and the initial 2ME concentration as 
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Fig. 6. 13C-GSH resonance intensity as a function of incubation time for 
paired rabbit lens incubated for 13 h in 1 mM [3-13C]cysteine m dium 
supplemented with 1 mM glutamic acid (O) prior to addition of 400 p.M 
2-mercaptoethanol to the incubation medium (O). Fitted lines were 
established by linear egression. 
steine could not be detected. However, when 2ME (200 
/xM) was added to the incubation medium (at 13 h of 13C 
incubation), intralenticular 13C-cysteine accumulation was 
readily observed, as shown by the appearance of resonance 
2. 
Cysteine uptake catalyzed by 2ME was antagonized by 
the addition of leucine to the organ culture medium. 
Shown in Fig. 8A-C  are 13C-NMR spectra from a pair of 
BSO incubated lenses maintained in organ culture obtained 
at the end of each of three incubation periods: (A) 1 mM 
13C-cysteine (0-10 h); (B) 1 mM t3C-cysteine plus 200 
/~M 2ME and 5 mM leucine (10-20 h) and (C) 1 mM 
13C-cysteine plus 200 ~M 2ME (20-40 h). As expected, 
in the absence of 2ME, lenticular 13C-cysteine was not 
observed (Fig 8A), nor could it be observed uring 2ME 
(200 /xM) incubation in the presence of 5 mM leucine 
(Fig. 8B). However, when leucine was removed from the 
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Fig. 8. (A) 13C-NMR spectra from paired rabbit lenses during sequential 
incubation i  (A) 1 mM [3J3C]cysteine medium supplemented with 2 
mM BSO; (B) 1 mM [3-13C]cysteine  the presence of 200 ~M 2ME 
and 5 mM leucine; (C) 1 mM [3-13C]cysteine and 200 /xM 2ME. 
Resonance assignments were as follows: (1) [3,3'-13C]-cystine (39.3 
ppm); (2) [3-13 C]cysteine (25.5 ppm). See Section 2 for lens organ 
culture methodology and NMR spectral acquisition and processing pa- 
rameters. 
be observed as shown by the appearance of resonance 2
(Fig 8C). 
Competitive antagonism of cysteine uptake by leucine 
was investigated by incubating paired lenses in organ 
culture medium containing BSO and 500 /zM leucine 
supplemented with 200 and 400 /xM 2ME. As shown by 
the 13C-NMR spectra in Fig. 9, cysteine uptake could not 
be readily observed in the presence of 200 /.tM 2ME, 
whereas when the concentration of 2ME was increased to 
400 /zM (at 14 h of incubation), intralenticular cysteine 
accumulation was readily detected. 
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Fig. 7. Serial 13C-NMR spectra of paired rabbit lenses during incubation 
in 1 mM [3-13C]cysteine m dium supplemented with 2 mM BSO. After 
14 h (designated byarrow), 200/zM 2-mercaptoethanol was added to the 
incubation medium• Resonance assignments were as follows: (1) [3,3'- 
13C]cystine (39.3 ppm); (2) [3J3C]cysteine (26.1 ppm). See Section 2for 
lens organ culture methodology anti NMR spectral acquisition and pro- 
cessing parameters• 




• 13  . . Fig. 9. C-NMR spectra (25.0-26.0 ppm spectral region) from paired 
13 rabbit lenses demonstrating thesynthesis of C-3-cysteine during incuba- 
tion in 1 mM [3-13C]cysteine m dium supplemented with 2 mM BSO, 
200 /zM 2ME, and 500 /zM L-leucine. At 14 h, indicated by the arrow, 
the concentration of 2ME was increased to400 /zM. 
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4. Discussion 
The avascular properties of the ocular lens allow it to be 
maintained in organ culture with concurrent non-invasive 
NMR spectroscopic analysis for extended periods of time 
as shown by Willis and Schleich [16]. The incorporation of
13C-cysteine into lenticular glutathione can be readily mon- 
itored in the intact lens by 13C-NMR spectroscopy [21]. 
This provided a non-invasive method to measure relative 
glutathione synthesis rates, and was employed in the pre- 
sent study to examine the dose response properties of 
glutathione synthesis rates to 2ME, and to examine the 
mechanism of action for this effect. 
The exposure of organ cultured, intact rabbit lenses to 
2ME exerts a pronounced effect on tissue glutathione 
levels (EDs0 = ~ 125 /xM). At the most effective concen- 
tration tested (400 /zM) 2ME increased the rate of glu- 
tathione synthesis over 160% relative to control lenses. 
This effect leveled off at higher 2ME concentrations, 
before dropping nearly 40% at 1 mM 2ME. Lenticular 
cysteine levels were also affected by the addition of 2ME 
to the culture medium. In the lenses studied, the detection 
of 13C-cysteine was dependent in a dose dependent manner 
on the presence of 2ME. 
The rate limiting factor for lenticular glutathione syn- 
thesis is the availability of cysteine [22]. The primary 
source of this amino acid is provided by cystine actively 
transported from the in vivo (in situ) fluids bathing the 
tissue. Because of low levels of cyst(e)ine in the humoral 
fluids surrounding the lens [23], and limited tissue uptake 
capacity [24], only trace amounts of cysteine are found in 
the lens. 
Cellular amino acid uptake occurs through membrane 
transport systems possessing discrete substrate specificity 
[25]. A cellular uptake system for cystine that also func- 
tions as a co-transport mechanism for L-glutamic acid (X~- 
or GC system transport) has been described [26]. This 
allows glutamic acid to be used as an antagonist of cellular 
cystine uptake. The activity of X c system transport in the 
rabbit lens was investigated by examining the effects of 
L-glutamic acid on glutathione synthesis. The addition of 1 
mM glutamic acid to the 13C-cysteine medium antagonized 
glutathione synthesis rates over 60% relative to the rates 
observed in control lenses. The relative rate of GSH 
synthesis recovered two-fold upon exposure of the lenses 
to 400 /zM 2ME. The primary source of lenticular gluta- 
mate is provided through glutamine glutaminase catalyzed 
deamination [27]. Consequently, glutamate uptake through 
X~-system transport is not a significant source of substrate 
for glutathione synthesis. 
The addition of 2ME to the incubation medium resulted 
in the formation of cysteine-2ME mixed-disulfide. The 
bulky neutral side chain characterizing this molecule sig- 
nificantly increases the affinity of cysteine for L system 
amino acid transport [14]. Once in the cell the mixed-dis- 
ulfide is reduced and 2ME diffuses from the tissue. This 
provides a pathway to increase cellular cysteine levels, 
thereby supplying additional substrate for glutathione syn- 
thesis. The possibility that the catalytic effect on GSH 
synthesis by 2ME was due to the formation of cysteine- 
mercaptoethanol mixed-disulfide in the incubation medium 
was investigated. L system transport is specific for long 
side chain neutral amino acids and is generally charac- 
terized by demonstrating competitive antagonism of uptake 
using other substrates (leucine, phenylalanine, tc.) for L 
system transport. This strategy was adopted to demonstrate 
L system transport specificity for cysteine-2-mercapto- 
ethanol mixed disulfide uptake in the intact lens. 
13C-cysteine l vels were measured in rabbit lenses incu- 
bated with BSO. These experiments demonstrated that the 
concentration of intralenticular cysteine observed uring 
incubation i  2ME supplemented medium could be antago- 
nized by leucine. The effect of this antagonism displayed a
dose response, was competitive with 2ME, and could be 
reversed when the antagonist was removed. These data 
suggest hat increased GSH synthesis with 2ME is the 
result of enhanced intracellular cysteine availability due to 
uptake of cysteine-2-mercaptoethanol mixed-disulfide by 
way of an L system amino acid uptake pathway. 
Amino acid uptake can be regulated through thiol/dis- 
ulfide equilibria involving transport system enzymes [28]. 
It is possible that the effects on lenticular cysteine uptake 
and glutathione synthesis hown by 2ME could be a 
consequence of its effects as a reducing agent on transport 
protein thiols. However, this possibility was discounted by 
the reported absence of increased glutathione synthesis in 
the presence of thiol reducing agents that are not capable 
of forming mixed-disulfide L system substrates (e.g., 
dithiothreitol [15,29]). 
Decreased 7-glutamylcysteine synthetase activity in the 
aging human lens compromises the ability of the tissue to 
synthesize glutathione [30], and is compounded by a de- 
crease in the cyst(e)ine uptake capacity of the human lens 
as a function of age [24]. Protein-glutathione mixed-dis- 
ulfide formation observed in lenses under oxidative stress 
results in pronounced reductions in the levels of free 
glutathione in the tissue [31,32]. Non-enzymatic glycation 
of cellular cysteine uptake mechanisms and the enzymes 
catalyzing glutathione synthesis may contribute to low 
glutathione levels in diabetic tissue [33]. In the present 
study, the characterization f a mechanism to increase 
lenticular glutathione l vels suggests a strategy for offset- 
ting depleted glutathione l vels associated with cataracto- 
genesis, thereby, providing a means to achieve potential 
anticataract therapy. 
Acknowledgements 
This research was supported by National Institutes of 
Health Grant EY 04033. 
J.A. Willis, T. Schleich / Biochimica et Biophysica Acta 1265 (1995) 1-7 7 
References 
[1] Varma, S.D. (1980) Curr. Top. Eye Res. 3, 91-155. 
[2] Chatterjee, A., Milton, R.C. and Thyle, S. (1982) Br. J. Ophthalmol. 
66, 35-42. 
[3] Harding, J.J. and Crabbe, J.C. (1984) in The Eye, Vol. 11 (Davson, 
H., ed.), pp. 205-392, Academic Press, New York. 
[4] Kuck, J. F, Yu, N.T. and Aslo'en, C.C. (1982) Exp. Eye Res. 34, 
23-37. 
[5] Calvin, H.I., Medvedovsky, C. and Worgul, B.V. (1986) Science 
233, 553-555. 
[6] Harding, J.J. (1970) Biochem. J. 117, 957-960. 
[7] Pau, H., Graf, P. and Sies, H. (1990) Exp. Eye Res. 50, 17-20. 
[8] Zigman, S., Datiles, M. and Torczynski, E. (1979) Invest. Ophthal- 
tool. Vis. Sci. 18, 462-467. 
[9] Hightower, K. and McCready, J. (1992) Curr. Eye Res. 11, 679-689. 
[10] Sippel, T.O. (1966) Invest. Ophthaimol. 5, 568-575. 
[11] Spector, A., Huang, R.R., Wang, G.M., Schmidt, C., Yan, G.Z. and 
Chifflet, S. (1987) Exp. Eye Res. 45, 453-465. 
[12] Garner, W.H., Conway, J., Dunn, M., Johnson, L. and Kaplan, L. 
(1988) Invest. Ophthalmol. Vis. Sci. 25 (suppl.) 147. 
[13] Martensson, J., Steinherz, R., J~tin, A. and Meister, A. (1989) Proc. 
Natl. Acad. Sci. USA 86, 8727--8731. 
[14] Ishii, T., Bannai, S. and Sugil:a, Y. (1981) J. Biol. Chem. 256, 
12387-12392. 
[15] Murray, D.L. and Rathbun, W.]3. (1990) Curr. Eye Res. 9, 55-63. 
[16] Willis, J.A. and Schleich, T. (1986) Exp. Eye Res. 43, 329-341. 
[17] Jung, G., Breitmaier, E., Gunzler, W.A., Ottnad, M., Volter, W. and 
Flohe, L. (1974) in Glutathione: Proceedings of the 16th Conference 
of the German Society of Biological Chemistry (Flohe, L., Behohr, 
H.Ch., Seis, H., Waller, H.D. and Wendel, A., eds.), pp. 1-14, 
Georg Thieme Publishers, Stuttgart. 
[18] Rabenstein, D.L. and Keire, D.A. (1989) in Glutathione: Chemical, 
Biochemical, and Medical Aspects (Dolphin, D., Paulson, R. and 
Avarmovic, O., eds.), Part A, pp. 67-101, John Wiley and Sons, 
New York. 
[19] Griffith, O.W. and Meister, A. (1979) J. Biol. Chem. 254, 7558- 
7560. 
[20] Gilbert, H.F. (1990) Adv. Enzymol. 63, 289-298. 
[21] Willis, J.A. and Schleich, T. (1992) Biochem. Biophys. Res. Com- 
mun. 186, 931-935. 
[22] Gander, J.E., Sethna, S.S. and Rathbun, W.B. (1983) Eur. J. 
Biochem. 133, 635-640. 
[23] Hockwin, I., Kietzmann, M.T., Vahar-Matiar, H. and Edelbi, A. 
(1979) Ophthalm. Res. 10, 250-258. 
[24] Rathbun, W.B. and Murray, D.L. (1991) Exp. Eye Res. 53, 205-212. 
[25] Christensen, H.N. (1979) (1979) Adv. Enzymol. 49, 41-101. 
[26] Bannai, S. and Kitamura, E. (1980) J. Biol. Chem. 255, 2372-2376. 
[27] Kern, J.L. and Ho, C.K. (1973) Exp. Eye Res. 17, 455-462. 
[28] Pola, E., Bertran, J., Roca, A., Palacin, M., Zorzano, A. and Testar, 
X. (1990) Biochem. J. 271, 297-303. 
[29] Rothwarf, D.M. and Scheraga, H.A. (1992) Proc. Natl. Acad. Sci. 
USA 89, 7944-7948. 
[30] Sentha, S.S., Holleschau, A.M. and Rathbun, W.B. (1992/93) Curr. 
Eye Res. 2, 735-742. 
[31] Cui, X.L. and Lou, M.F. (1993) Exp. Eye Res. 55, 157-167. 
[32] Willis, J.A. and Schleich, T., in preparation. 
[33] Murakami, K., Kondo, T., Ohtsuka, Y., Fujiwara, Y, Shimada, M. 
and Kawakami, Y. (1989) Clin. Exp. Metab. 38, 753-758. 
